NEW YORK (GenomeWeb) — Rosetta Genomics said today that it has received final approval from the New York State Department of Health for use of its Rosetta Kidney Cancer Test on patient samples from the state.

Rosetta Genomics has been offering its Kidney Cancer Test in New York under conditional approval since December and now has full approval in all 50 US states.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.